Presentation Information
[P3-04-20]Experience using MGPT for hereditary tumors developed at our hospital and the need for EQA
○Kazuyuki Matushita1,2,3, Takayuki Ishige1, Motoi Nishimura1,2,3, Noriko Oonishi2, Tomohiko Ichikawa2,3 (1.Department of Laboratory Medicine, Chiba University Hospital, Japan, 2.Division of Clinical Genetics, Chiba University Hospital, Japan, 3.Center for Cancer Genomes, Chiba University Hospital, Japan)